GlassScriptPhysician profile
Hussein O Ads
NPI 1801966940
$2,418.82
in general payments reported to CMS, 2019-2025
13 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $149 · 2021: $327 · 2022: $476 · 2023: $408 · 2024: $165 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $815.19 | 2019-2023 | Nobelactive |
| Straumann USA LLC | $371.38 | 2019-2025 | |
| Biohorizons Implant Systems INC. | $320.84 | 2021-2025 | Biohorizons, Biohorizons Dental Implants |
| Dentsply Sirona INC | $291.55 | 2019-2024 | Astra Tech Implant System |
| Geistlich Pharma, North America, INC. | $229.39 | 2020-2022 | |
| Ace Surgical Supply Co., INC. | $84.22 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $77.01 | 2019 | |
| Envista Holdings Corporation | $73.41 | 2025 | Spark |
| Stryker Corporation | $52.92 | 2023 | Vsp System, Vsp Cranial |
| Salvin Dental Specialties, INC. | $40.50 | 2021 | |
| Kls-Martin L.P. | $25.59 | 2024 | |
| Dentsply Ih INC. | $19.80 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $17.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hussein Ads listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.